Benzinga · Aug 20, 2026
BTIG Maintains Buy on LENSAR, Raises Price Target to $10
BTIG analyst Ryan Zimmerman maintains LENSAR (NASDAQ:LNSR) with a Buy and raises the price target from $9 to $10.
LN
NASDAQ · LNSR
LENSAR, Inc.
Healthcare · Medical - Devices
$8.31
Down-$0.26 (-3.13%)
Updated Sep 10, 2026, 9:35 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 137.6M
- P/E ratio
- -2.79
- Dividend yield
- 0.00%
- 52-week range
- $4.95 – $11.99
- Volume
- 68.93K
- Avg. volume
- 56.53K
Price performance
LNSR price history
1M range · 0 trading sessions · Daily adjusted prices
LNSR does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest LNSR news
The latest Smart Investors Daily articles mentioning LNSR.
Stock researchCompany · Overview
LNSR research
Overview
Company profile and research snapshot.
Company profile
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 20, 2026 | BTIG | Buy | — |
| Aug 13, 2026 | BTIG | Buy | — |
| Mar 18, 2026 | BTIG | Buy | — |
| Mar 24, 2025 | Lake Street | Hold | — |
| Feb 28, 2025 | Lake Street | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 13, 2026
BTIG Maintains Buy on LENSAR, Raises Price Target to $9
BTIG analyst Ryan Zimmerman maintains LENSAR (NASDAQ:LNSR) with a Buy and raises the price target from $7 to $9.
SeekingAlpha · Aug 13, 2026
LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript
LENSAR, Inc. (LNSR) Q2 2026 Earnings Call August 13, 2026 8:30 AM EDTCompany ParticipantsNicholas Curtis - President, CEO & DirectorMichael Rossi -...
Benzinga · Aug 13, 2026
LENSAR Q2 2026 Earnings Call: Complete Transcript
LENSAR (NASDAQ:LNSR) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
